Compare Bristol-Myers Squibb Co (BMY) vs Capital One Financial Corp. (COF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Capital One Financial Corp. — how do they compare? Bristol-Myers Squibb Co trades at $63.63 (market cap $129.94B), while Capital One Financial Corp. trades at $219.35 (market cap $134.45B). The key difference: Bristol-Myers Squibb Co and Capital One Financial Corp. are close in size by market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | COF | |
|---|---|---|
Market Cap | $129.94B | $134.45B |
Sector | Health | Financials |
52-Week High | $65.89 | $257.94 |
52-Week Low | $42.60 | $176.10 |
Enterprise Value | $163.92B | — |
Dividend Yield | 3.96% | 1.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Capital One Financial Corp.
Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →
